The nation of Zimbabwe has rejected a significant US health deal valued at 367 million US dollars (272 million pounds) over five years because of Washington's insistence on sensitive data.
This rejection came to light following a government memo dated December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the arrangement was "skewed".
A government representative later clarified that the US was demanding access to biological samples for scientific study and profit but was unwilling to guarantee the benefits from any future medical innovations.
"We are forced to start the difficult and regrettable process of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had provided more than $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has appealed for further negotiations to reach a agreement agreeable to both sides so the country's critical HIV programme can proceed.
Broader Background
This development follows a comparable situation in neighbouring Kenya, where a high court blocked a similar deal with the US following legal challenges were filed about the safety of Kenyans' health data.
After resuming the presidency recently, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
The agency had overseen assistance for the US government, but Trump claimed its expenditure was "inefficient" and his government was pursuing direct bilateral deals to boost openness and accountability.
As per statements, Sixteen African countries have to date signed these new agreements, representing over $18.3bn of fresh investment.
Specifics of the Rejected Agreement
This assistance for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this partnership could have provided extraordinary advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently on HIV treatment via American-funded programmes," Tremont added.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"The proposal required Zimbabwe to share its genetic material and health information for a long time, without any equivalent assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that shared data," he stated.
"Effectively, our country would supply the raw materials for scientific discovery with no certainty that the final treatments would be available to our population if a future pandemic emerge."
Sovereignty and International Frameworks
He also said that the American exit from the global health body and its push of one-on-one deals were upending structures already established via the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage potential global health emergencies.
"This mechanism is designed to guarantee that when a country provides its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to develop them."
Zimbabwe's reservations regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We encourage ongoing dialogue with our American counterparts on how future collaboration might be arranged in a way that honours the independence and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but suggested that negotiations need to persist given that much of the country's Aids initiatives depended on external financing.
"In cases where technical issues arise, such as those involving information security or agreement terms, these can often be resolved through detailed discussion and negotiated safeguards," the group said.
The halted deal highlights the continuing challenges between receiving much-needed international aid and safeguarding a country's data in an ever more interconnected world.